Narrower margins for clinical stage I malignant melanoma.

Panic after a diagnosis of cutaneous malignant melanoma commonly arises from fears of early death and disfiguring surgery. Yet, in the United States today, most cutaneous melanomas are diagnosed wh...

[1]  M. Mihm,et al.  Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis , 1982 .

[2]  M. Mihm,et al.  Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions , 1982, Annals of surgery.

[3]  M. Mihm,et al.  A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. , 1982, Annals of surgery.

[4]  M. Mihm,et al.  The natural break points for primary-tumor thickness in clinical Stage I melanoma. , 1981, The New England journal of medicine.

[5]  M. Mihm,et al.  A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. , 1981, American journal of surgery.

[6]  M. Mihm,et al.  Malignant Melanoma: Prognostic Significance of “Microscopic Satellites” in the Reticular Dermis and Subcutaneous Fat , 1981, Annals of surgery.

[7]  M. Mihm,et al.  A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. , 1981, Surgery.

[8]  B. Cady,et al.  Changes in clinical presentation and management of malignant melanoma , 1981, Cancer.

[9]  M. Mihm,et al.  A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease , 1981, Annals of surgery.

[10]  M C Mihm,et al.  Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes , 1981, Cancer.

[11]  M. Griffel,et al.  Survival of cutaneous malignant melanoma patients at university of lowa hospitals: 1950–1974 , 1981, Cancer.

[12]  Institut Gustave Roussy,et al.  Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma , 1980, International journal of cancer.

[13]  N. Davis,et al.  CHANGING EPIDEMIOLOGY OF MALIGNANT MELANOMA IN QUEENSLAND , 1980, The Medical journal of Australia.

[14]  C. Balch,et al.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients , 1979, Cancer.

[15]  C. Balch,et al.  A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. , 1979, Surgery.

[16]  L. Peterson,et al.  Prognostic Factors in Cutaneous Malignant Melanoma in Stage I: A Clinical, Morphological and Multivariate Analysis , 1978 .

[17]  J. Everall,et al.  DIAGNOSIS, PROGNOSIS, AND TREATMENT OF MELANOMA , 1977, The Lancet.

[18]  Goldman Li.  The surgical therapy of malignant melanomas. , 1975 .

[19]  S. Waltman,et al.  Glaucoma and HL-A antigens , 1975, The Lancet.

[20]  C. Wong.  A study of melanocytes in the normal skin surrounding malignant melanomata. , 1970, Dermatologica.

[21]  A. Cochran.  Histology and prognosis in malignant melanoma , 1969, The Journal of pathology.

[22]  F. S. Cross,et al.  Clinical study of forty‐nine patients with malignant melanoma , 1966, Cancer.

[23]  N. Petersen,et al.  Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I. , 1962, British journal of plastic surgery.

[24]  G. Pack,et al.  End results in the treatment of malignant melanoma; a later report. , 1952, Surgery.